HJHongbin Jiao
Hongbin Jiao
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hongbin Jiao has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Fenfang Zou
Department of Respiratory, The Third Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
1 shared publication - Guoan Xiang
Department of Respiratory, The Third Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
1 shared publication - Hongmei Gao
Department of Respiratory, The Third Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
1 shared publication - Jianpeng Zhang
Department of Respiratory Medicine, the Third Medical Centre of Chinese PLA General Hospital, Yongding Road No.69, Beijing, 100853 China
1 shared publication
Latest Publications
- Open Access
- 25 February 2019
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2019, 1-10
Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis
Published data on the association between MMP-9 polymorphisms (−1562 C > T, rs3918242; Gln279Arg, rs17576 Arg668Gln, rs17577) and asthma susceptibility are inconclusive. To derive a more precise estimation of this association, a meta-analysis was performed. A literature search was conducted in PubMed, Web of Science, EMBASE, Wanfang, and China National Knowledge Infrastructure (CNKI) databases to identify eligible studies. The pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to calculate the strength of association. Sensitivity analysis was performed to evaluate the influence of individual studies on the overall effect estimates, and funnel plots and Egger’s test were inspected for indication of publication bias. Seven studies with 1592 asthma patients and 1987 controls were finally identified. Overall, we found no significant association between −1562 C > T, rs3918242 polymorphism, and asthma susceptibility in any of the genetic model comparisons. After categorizing studies into different subgroups on the basis of ethnicity and age, there is still no significant association. For the Gln279Arg, rs17576 polymorphism, there seems to be a significant association in the allelic genetic model in regard to the value (OR = 1.11, 95% CI = 1.00–1.22, I2 = 0%, ); however, the value of lower 95% CI is 1.0. For the Arg668Gln, rs17577 polymorphism, a high significant association was observed in the dominant model comparison (OR = 1.65, 95% CI = 1.28–2.11, I2 = 22.50%, ), recessive model comparison (OR = 2.40, 95% CI = 1.23–4.72, I2 = 0%, ), homozygote genotype comparison (OR = 2.69, 95% CI = 1.36–5.33, I2 = 0%, ), and allelic genetic model (OR = 1.59, 95% CI = 1.29–1.97, I2 = 36.9%, ). Sensitivity analysis demonstrated the stability of our results, and publication bias was not evident. The present meta-analysis suggests that MMP-9 Arg668Gln, rs17577 polymorphism may be the risk factor for asthma susceptibility.- 25 February 2019
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2019, 1-10
Open AccessAssociation of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis
Published data on the association between MMP-9 polymorphisms (−1562 C > T, rs3918242; Gln279Arg, rs17576 Arg668Gln, rs17577) and asthma susceptibility are inconclusive. To derive a more precise estimation of this association, a meta-analysis was performed. A literature search was conducted in PubMed, Web of Science, EMBASE, Wanfang, and China National Knowledge Infrastructure (CNKI) databases to identify eligible studies. The pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to calculate the strength of association. Sensitivity analysis was performed to evaluate the influence of individual studies on the overall effect estimates, and funnel plots and Egger’s test were inspected for indication of publication bias. Seven studies with 1592 asthma patients and 1987 controls were finally identified. Overall, we found no significant association between −1562 C > T, rs3918242 polymorphism, and asthma susceptibility in any of the genetic model comparisons. After categorizing studies into different subgroups on the basis of ethnicity and age, there is still no significant association. For the Gln279Arg, rs17576 polymorphism, there seems to be a significant association in the allelic genetic model in regard to the value (OR = 1.11, 95% CI = 1.00–1.22, I2 = 0%, ); however, the value of lower 95% CI is 1.0. For the Arg668Gln, rs17577 polymorphism, a high significant association was observed in the dominant model comparison (OR = 1.65, 95% CI = 1.28–2.11, I2 = 22.50%, ), recessive model comparison (OR = 2.40, 95% CI = 1.23–4.72, I2 = 0%, ), homozygote genotype comparison (OR = 2.69, 95% CI = 1.36–5.33, I2 = 0%, ), and allelic genetic model (OR = 1.59, 95% CI = 1.29–1.97, I2 = 36.9%, ). Sensitivity analysis demonstrated the stability of our results, and publication bias was not evident. The present meta-analysis suggests that MMP-9 Arg668Gln, rs17577 polymorphism may be the risk factor for asthma susceptibility.